Search filters

List of works by Eliza A Hawkes

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer

scientific article

A consensus statement on the use of biosimilar medicines in hematology in Australia

scientific article published on 14 April 2020

A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma.

scientific article

A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma

scientific article published on 24 May 2019

ASPECCT: panitumumab versus cetuximab for colorectal cancer

scientific article published in July 2014

Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial

scientific article published on 01 February 2000

An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma

scientific article published on 23 March 2018

Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer?

scientific article

Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?

scientific article

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

scientific article

Can PET eradicate irradiation in PMBCL?

scientific article published on 01 December 2020

Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible

scientific article published on 20 June 2011

Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCL

scientific article published on 26 October 2020

Caution in the Use of Immunohistochemistry for Determination of Cell of Origin in Diffuse Large B-Cell Lymphoma.

scientific article

Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.

scientific article published in October 2017

Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support

scientific article published on 03 November 2017

Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations

scientific article published on 17 June 2019

Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma

scientific article published on 19 September 2019

Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.

scientific article

Diagnosis and management of rare gastrointestinal lymphomas

scientific article published on 21 June 2012

Diagnostic medical radiation exposure in surveillance of aggressive lymphoma: clinical trial design should reflect clinical practice

scientific article published on 17 February 2015

Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer.

scientific article published on 25 January 2011

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care

scientific article published on 01 March 2019

Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.

scientific article published on 28 October 2016

EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

scientific article published on 17 November 2020

Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study

scientific article published on 21 March 2018

Effect of Reasons for Screen Failure on Subsequent Treatment Outcomes in Cancer Patients Assessed for Clinical Trials

scientific article published on 02 July 2019

Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era.

scientific article

Flexible sigmoidoscopy—valuable in colorectal cancer ⬇️

scientific article published on September 1, 2010

GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma

scientific article

Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.

scientific article

Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience

scientific article published on 16 July 2020

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma

scientific article published on 22 April 2022

Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer

scientific article published on 10 May 2011

Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

scientific article published on 28 October 2016

Limited utility of routine chest X-ray in initial evaluation of neutropenic fever in patients with haematological diseases undergoing chemotherapy.

scientific article

Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study

scientific article published on 29 September 2020

Metastatic breast cancer presenting as a primary hindgut neuroendocrine tumour

scientific article published on July 2010

Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatment

scientific article published on 11 April 2017

Mycosis fungoides and Sézary syndrome: Australian clinical practice statement

scientific article published on 26 December 2020

Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm?

scientific article published on July 2011

Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies.

scientific article published on 21 March 2018

Outcome of Elderly Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP: Results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial

scientific article

Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital

scientific article published on 9 November 2017

Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013.

scientific article published on 8 December 2016

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

scientific article published on 01 October 2019

Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance

scientific article published on 24 June 2019

Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma

scientific article published on 17 December 2019

Pembrolizumab in relapsed or refractory Richter syndrome

scientific article published on 16 June 2020

Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases

scientific article

Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study

scientific article published on 07 October 2020

Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer

scientific article published on December 2010

Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial

scientific article published on 20 May 2020

Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI.

scientific article published on 26 March 2018

Programmed cell death-1 inhibition in lymphoma.

scientific article published on May 2015

Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy?

scientific article published on 01 October 2007

Rare case of precursor B-cell acute lymphoblastic leukemia presenting as a solitary paraspinal mass alone.

scientific article

Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.

scientific article published on 8 December 2010

Relationship Between Colorectal Cancer Biomarkers and Response to Epidermal Growth Factor Receptor Monoclonal Antibodies ⬇️

scientific article published on August 2, 2010

Reply to M. Mohiuddin et al

scientific article published in July 2011

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

scientific article

Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma

scientific article

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial

scientific article published in August 2016

Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression

scientific article published on 25 June 2020

Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission

scientific article published on 23 July 2018

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

scientific article published on 14 February 2020

The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management

scientific article published on 19 September 2011

Treatment of metastatic colorectal cancer: focus on panitumumab

scientific article

Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab.

scientific article published on 12 August 2016

Upper Gastrointestinal Malignancies: A New Era in Clinical Colorectal Cancer

scientific article published in October 2009

Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients

scientific article published on 27 September 2018

Paulina is supported by:

About Paulina

Help